DK2162529T3 - Selektiv celleterapi til behandling af nyresvigt - Google Patents
Selektiv celleterapi til behandling af nyresvigt Download PDFInfo
- Publication number
- DK2162529T3 DK2162529T3 DK08768234.0T DK08768234T DK2162529T3 DK 2162529 T3 DK2162529 T3 DK 2162529T3 DK 08768234 T DK08768234 T DK 08768234T DK 2162529 T3 DK2162529 T3 DK 2162529T3
- Authority
- DK
- Denmark
- Prior art keywords
- renewal
- treatment
- selective cell
- cell tape
- tape
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/1031—Investigating individual particles by measuring electrical or magnetic effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/25—Urinary tract cells, renal cells
- C12N2502/256—Renal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N2015/1028—Sorting particles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Dispersion Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Neurosurgery (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94271607P | 2007-06-08 | 2007-06-08 | |
PCT/US2008/007161 WO2008153970A1 (en) | 2007-06-08 | 2008-06-06 | Selective cell therapy for the treatment of renal failure |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2162529T3 true DK2162529T3 (da) | 2019-07-01 |
Family
ID=39745597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK08768234.0T DK2162529T3 (da) | 2007-06-08 | 2008-06-06 | Selektiv celleterapi til behandling af nyresvigt |
Country Status (11)
Country | Link |
---|---|
US (2) | US20080305146A1 (da) |
EP (1) | EP2162529B1 (da) |
JP (3) | JP2010528658A (da) |
KR (3) | KR101632372B1 (da) |
CN (2) | CN103865871A (da) |
AU (1) | AU2008262333B2 (da) |
CA (1) | CA2688265C (da) |
DK (1) | DK2162529T3 (da) |
ES (1) | ES2725502T3 (da) |
HK (1) | HK1199059A1 (da) |
WO (1) | WO2008153970A1 (da) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0214217A (pt) * | 2001-11-16 | 2004-09-21 | Childrens Medical Center | Aumento de função de órgão |
ES2725502T3 (es) * | 2007-06-08 | 2019-09-24 | Univ Wake Forest Health Sciences | Terapia celular selectiva para el tratamiento de la insuficiencia renal |
US10590391B2 (en) | 2007-06-08 | 2020-03-17 | Wake Forest University Health Sciences | Selective cell therapy for the treatment of renal failure |
JP5974233B2 (ja) | 2008-11-12 | 2016-08-24 | リージェンメド(ケイマン)エルティーディー. | 単離した腎細胞およびその使用 |
WO2011026939A2 (de) * | 2009-09-04 | 2011-03-10 | Fachhochschule Giessen-Friedberg | Vorrichtung und verfahren zur expansion, ernte und differenzierung von stammzellen |
AU2011252915B2 (en) * | 2010-05-12 | 2016-05-19 | Prokidney | Bioactive renal cells |
JP2013116854A (ja) * | 2010-06-10 | 2013-06-13 | Kyoto Univ | エリスロポエチンの製造方法およびエリスロポエチン産生細胞の単離方法 |
CA3065694A1 (en) | 2010-11-10 | 2012-05-18 | Inregen | Methods of forming injectable formulations for providing regenerative effects to an organ such as a kidney |
US20130130373A1 (en) * | 2011-11-11 | 2013-05-23 | Essential Pharmaceuticals, Llc | Kit Comprising Serum Replacement and Labile Factors |
EP3567099B1 (en) * | 2012-10-24 | 2021-04-21 | ProKidney | Renal cell populations and uses thereof |
CA3030442A1 (en) | 2016-07-14 | 2018-01-18 | Qidni Labs, Inc. | Biocompatible and hemocompatible material and filter |
US11123372B2 (en) | 2016-07-29 | 2021-09-21 | Prokidney | Bioactive renal cells for the treatment of chronic kidney disease |
KR101782768B1 (ko) | 2016-08-26 | 2017-09-28 | 주식회사 피시피아비아이티 | 신장질환 조기 진단용 바이오마커 sbp1 및 이의 이용 |
US10767164B2 (en) | 2017-03-30 | 2020-09-08 | The Research Foundation For The State University Of New York | Microenvironments for self-assembly of islet organoids from stem cells differentiation |
CN109157691A (zh) * | 2018-06-15 | 2019-01-08 | 翁炳焕 | 猴-鼠细胞融合母胎血型不合治疗杂交株的制备 |
US11194429B2 (en) | 2019-09-05 | 2021-12-07 | Panasonic Intellectual Property Management Co., Ltd. | Information display terminal |
Family Cites Families (103)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3463158A (en) * | 1963-10-31 | 1969-08-26 | American Cyanamid Co | Polyglycolic acid prosthetic devices |
JPS5492580A (en) | 1977-12-29 | 1979-07-21 | Nippon Zeon Co Ltd | Hollow fiber type material transferring apparatus |
US4182339A (en) * | 1978-05-17 | 1980-01-08 | Hardy Thomas G Jr | Anastomotic device and method |
JPS6045849B2 (ja) * | 1980-08-25 | 1985-10-12 | 林原 健 | ヒトエリトロポエチンの製造方法 |
SU1034717A1 (ru) | 1981-04-22 | 1983-08-15 | Рижский Медицинский Институт | Способ наложени сосудистого анастомоза |
US4458678A (en) * | 1981-10-26 | 1984-07-10 | Massachusetts Institute Of Technology | Cell-seeding procedures involving fibrous lattices |
US4520821A (en) * | 1982-04-30 | 1985-06-04 | The Regents Of The University Of California | Growing of long-term biological tissue correction structures in vivo |
US4594407A (en) * | 1983-09-20 | 1986-06-10 | Allied Corporation | Prosthetic devices derived from krebs-cycle dicarboxylic acids and diols |
FR2577807B1 (fr) | 1985-02-22 | 1993-12-03 | Ethnor | Materiau chirurgical composite absorbable, procede de preparation, prothese resorbable realisee a partir d'un tel materiau et utilisation d'une telle prothese |
US5032508A (en) | 1988-09-08 | 1991-07-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US5266480A (en) * | 1986-04-18 | 1993-11-30 | Advanced Tissue Sciences, Inc. | Three-dimensional skin culture system |
US4963489A (en) * | 1987-04-14 | 1990-10-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US5902741A (en) * | 1986-04-18 | 1999-05-11 | Advanced Tissue Sciences, Inc. | Three-dimensional cartilage cultures |
US5160490A (en) * | 1986-04-18 | 1992-11-03 | Marrow-Tech Incorporated | Three-dimensional cell and tissue culture apparatus |
US5863531A (en) * | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
US4769037A (en) * | 1986-10-28 | 1988-09-06 | Midcalf Robert J | Artificial replacement kidney implant and method of dialyzing blood |
CA1340581C (en) * | 1986-11-20 | 1999-06-08 | Joseph P. Vacanti | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
US5759830A (en) * | 1986-11-20 | 1998-06-02 | Massachusetts Institute Of Technology | Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo |
US5567612A (en) * | 1986-11-20 | 1996-10-22 | Massachusetts Institute Of Technology | Genitourinary cell-matrix structure for implantation into a human and a method of making |
WO1989001967A1 (en) | 1987-09-03 | 1989-03-09 | Brown University Research Foundation | Blood purification with cultured renal cells |
GB8722854D0 (en) * | 1987-09-29 | 1987-11-04 | Hardy S M | Implantable artificial kidney |
US5085629A (en) * | 1988-10-06 | 1992-02-04 | Medical Engineering Corporation | Biodegradable stent |
CN1053698C (zh) * | 1989-01-19 | 2000-06-21 | 南京大学 | 细胞培养生产促红细胞生成素的方法 |
US5429936A (en) * | 1989-04-21 | 1995-07-04 | The Regents Of The University Of California | Antibody-mediated juxtaposition of reactive moieties |
DE3913756A1 (de) | 1989-04-21 | 1990-10-25 | Schering Ag | 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung |
AU636346B2 (en) | 1989-04-25 | 1993-04-29 | Children's Hospital | Method for implanting large volumes of cells on polymeric matrices |
US4996154A (en) * | 1989-05-04 | 1991-02-26 | Millipore Corporation | Method for growing cellular tissue |
WO1991009625A1 (en) | 1989-12-21 | 1991-07-11 | Tanox Biosystems, Inc. | Monoclonal antibodies which neutralize hiv-1 infection and their anti-idiotypes |
US5261898A (en) * | 1990-11-13 | 1993-11-16 | Polin Stanton G | Temporary colostomy apparatus |
US5192312A (en) | 1991-03-05 | 1993-03-09 | Colorado State University Research Foundation | Treated tissue for implantation and methods of treatment and use |
AU2900792A (en) * | 1991-10-24 | 1993-05-21 | Children's Medical Center Corporation | Neomorphogenesis of urological structures in vivo from cell culture |
NZ245015A (en) * | 1991-11-05 | 1995-12-21 | Transkaryotic Therapies Inc | Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production |
US5376376A (en) * | 1992-01-13 | 1994-12-27 | Li; Shu-Tung | Resorbable vascular wound dressings |
US6060270A (en) * | 1992-03-02 | 2000-05-09 | The University Of Michigan | Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules |
US6410320B1 (en) * | 1992-03-02 | 2002-06-25 | The University Of Michigan | Method and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules |
US5429938A (en) * | 1992-03-02 | 1995-07-04 | University Of Michigan | Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules |
US5549674A (en) * | 1992-03-02 | 1996-08-27 | The Regents Of The University Of Michigan | Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo |
US5441870A (en) * | 1992-04-15 | 1995-08-15 | Athena Neurosciences, Inc. | Methods for monitoring cellular processing of β-amyloid precursor protein |
EP0637229B1 (en) * | 1992-04-24 | 2002-11-20 | Osteotech, Inc., | Devices for preventing tissue adhesion |
US5224953A (en) * | 1992-05-01 | 1993-07-06 | The Beth Israel Hospital Association | Method for treatment of obstructive portions of urinary passageways |
US5800537A (en) * | 1992-08-07 | 1998-09-01 | Tissue Engineering, Inc. | Method and construct for producing graft tissue from an extracellular matrix |
US5957972A (en) * | 1992-09-29 | 1999-09-28 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Implants possessing a surface of endothelial cells genetically-modified to inhibit intimal thickening |
US5514378A (en) * | 1993-02-01 | 1996-05-07 | Massachusetts Institute Of Technology | Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures |
US5433996A (en) * | 1993-02-18 | 1995-07-18 | W. L. Gore & Associates, Inc. | Laminated patch tissue repair sheet material |
US5709854A (en) * | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
AU1931495A (en) * | 1994-03-14 | 1995-10-03 | Cryolife, Inc. | Treated tissue for implantation and preparation methods |
US5916265A (en) * | 1994-03-30 | 1999-06-29 | Hu; Jie | Method of producing a biological extracellular matrix for use as a cell seeding scaffold and implant |
US5626861A (en) * | 1994-04-01 | 1997-05-06 | Massachusetts Institute Of Technology | Polymeric-hydroxyapatite bone composite |
US5947893A (en) * | 1994-04-27 | 1999-09-07 | Board Of Regents, The University Of Texas System | Method of making a porous prothesis with biodegradable coatings |
US5545131A (en) * | 1994-04-28 | 1996-08-13 | White Eagle International Technologies, Lp | Artificial kidney |
JPH10511563A (ja) | 1994-09-12 | 1998-11-10 | アドバンスド ティシュー サイエンシズ,インコーポレーテッド | 心臓弁枠組み上での三次元ヒト細胞培養物およびその使用 |
US5429674A (en) * | 1994-09-12 | 1995-07-04 | Ppg Industries, Inc. | N-acyl aminomethylene phosphonates and their use in waterborne coating compositions |
US5654273A (en) * | 1994-09-22 | 1997-08-05 | Children's Medical Center Corporation | Synducin mediated modulation of tissue repair |
US5695996A (en) * | 1994-09-23 | 1997-12-09 | The United States Of America As Represented By The Department Of Health And Human Services | Artificial organ culture system |
US5716404A (en) * | 1994-12-16 | 1998-02-10 | Massachusetts Institute Of Technology | Breast tissue engineering |
JPH11508151A (ja) * | 1995-04-07 | 1999-07-21 | パーデュー・リサーチ・ファウンデーション | 膀胱再建方法及び膀胱再建用組織グラフト |
US5855610A (en) * | 1995-05-19 | 1999-01-05 | Children's Medical Center Corporation | Engineering of strong, pliable tissues |
JP3816534B2 (ja) | 1996-08-16 | 2006-08-30 | チルドレンズ メディカル センター コーポレーション | 細胞を接種された組織再建術用膀胱粘膜下組織 |
US6171344B1 (en) * | 1996-08-16 | 2001-01-09 | Children's Medical Center Corporation | Bladder submucosa seeded with cells for tissue reconstruction |
ATE260076T1 (de) * | 1996-09-05 | 2004-03-15 | Childrens Medical Center | Nierenprothese |
US6673339B1 (en) * | 1996-09-05 | 2004-01-06 | Children's Medical Center Corporation | Prosthetic kidney and its use for treating kidney disease |
US5952226A (en) * | 1996-11-05 | 1999-09-14 | Modex Therapeutiques | Hypoxia responsive EPO producing cells |
US5967972A (en) * | 1997-03-28 | 1999-10-19 | Kapp Surgical Instrument, Inc. | Minimally invasive surgical retractor and method of operation |
ES2231980T3 (es) | 1997-04-11 | 2005-05-16 | Cryolife, Inc. | Descelurizacion de un tejido. |
JP2002507907A (ja) | 1997-06-27 | 2002-03-12 | バーダー、アウグスチヌス | 生合成移植片及びその製造方法 |
ATE328617T1 (de) | 1997-10-31 | 2006-06-15 | Childrens Medical Center | Penis-rekonstruktion |
US6576019B1 (en) | 1997-10-31 | 2003-06-10 | Children's Medical Center Corporation | Bladder reconstruction |
EP0984062A1 (en) | 1998-09-04 | 2000-03-08 | Cytos Biotechnology AG | Production of human erythropoietin |
US6777205B1 (en) * | 1998-11-06 | 2004-08-17 | Sterrenbeld Biotechnologie North America, Inc. | Host cells expressing recombinant human erythropoietin |
DE19919625C2 (de) | 1999-04-29 | 2002-10-31 | Symetis Ag Zuerich | In-vitro-Verfahren zum Herstellen einer homologen Herzklappe und durch dieses Verfahren herstellbare Klappe |
US6455311B1 (en) | 1999-04-30 | 2002-09-24 | The General Hospital Corporation | Fabrication of vascularized tissue |
GB9910377D0 (en) | 1999-05-05 | 1999-06-30 | Univ Westminster | Tissue engineering |
CN1367701A (zh) * | 1999-05-11 | 2002-09-04 | 奥索-麦克尼尔药物公司 | 红细胞生成素给药的药代动力学和药效模型 |
US20040167634A1 (en) * | 1999-05-26 | 2004-08-26 | Anthony Atala | Prosthetic kidney and its use for treating kidney disease |
KR100369788B1 (ko) * | 1999-09-03 | 2003-01-29 | 동아제약 주식회사 | 재조합 인간 에리트로포이에틴의 제조방법 |
JP3603179B2 (ja) | 1999-09-09 | 2004-12-22 | グンゼ株式会社 | 心血管系組織培養用基材および組織再生法 |
US20030180289A1 (en) * | 1999-09-23 | 2003-09-25 | Foster Keith Alan | Inhibition of secretion from non-neuronal cells |
US6503330B1 (en) * | 1999-12-22 | 2003-01-07 | Genus, Inc. | Apparatus and method to achieve continuous interface and ultrathin film during atomic layer deposition |
US6376244B1 (en) | 1999-12-29 | 2002-04-23 | Children's Medical Center Corporation | Methods and compositions for organ decellularization |
US6368859B1 (en) * | 1999-12-29 | 2002-04-09 | Children's Medical Center Corporation | Methods and compositions for producing a fascial sling |
US6428802B1 (en) | 1999-12-29 | 2002-08-06 | Children's Medical Center Corp. | Preparing artificial organs by forming polylayers of different cell populations on a substrate |
US6479064B1 (en) | 1999-12-29 | 2002-11-12 | Children's Medical Center Corporation | Culturing different cell populations on a decellularized natural biostructure for organ reconstruction |
US7326570B2 (en) * | 2000-06-16 | 2008-02-05 | The Regents Of The University Of California | Induction of tubular morphogenesis using pleiotrophin |
KR20030046411A (ko) | 2000-09-08 | 2003-06-12 | 그리폰 테라퓨틱스, 인코포레이티드 | '위'-천연 화학적 라이게이션 |
WO2002061053A1 (en) * | 2001-01-31 | 2002-08-08 | The General Hospital Corporation | Renal stem cells and uses thereof |
US6656488B2 (en) * | 2001-04-11 | 2003-12-02 | Ethicon Endo-Surgery, Inc. | Bioabsorbable bag containing bioabsorbable materials of different bioabsorption rates for tissue engineering |
FR2824072B1 (fr) | 2001-04-27 | 2004-03-12 | Centre Nat Rech Scient | Procede de replication et de production du virus de l'hepatite c |
US6784154B2 (en) * | 2001-11-01 | 2004-08-31 | University Of Utah Research Foundation | Method of use of erythropoietin to treat ischemic acute renal failure |
BR0214217A (pt) * | 2001-11-16 | 2004-09-21 | Childrens Medical Center | Aumento de função de órgão |
US20030180268A1 (en) * | 2002-02-05 | 2003-09-25 | Anthony Atala | Tissue engineered construct for supplementing or replacing a damaged organ |
AU2003253992A1 (en) * | 2002-07-18 | 2004-02-09 | Robert P. Bennett | Viral vectors containing recombination sites |
US8940292B2 (en) * | 2003-01-28 | 2015-01-27 | Wake Forest University Health Sciences | Enhancement of angiogenesis to grafts using cells engineered to produce growth factors |
AU2004229465B2 (en) * | 2003-04-09 | 2010-04-29 | The United States Of America Department Of Veterans Affairs | Compositions and methods related to production of erythropoietin |
WO2005007175A2 (en) * | 2003-06-09 | 2005-01-27 | The Brigham And Women's Hospital, Inc. | Cadherin directed molecular and cellular localization |
AU2003903896A0 (en) * | 2003-07-28 | 2003-08-07 | Queensland University Of Technology | Skin regeneration system |
EP1660663A4 (en) * | 2003-08-12 | 2007-07-11 | Brigham & Womens Hospital | METHODS AND COMPOSITIONS FOR TISSUE REGENERATION |
EP1548031A1 (en) * | 2003-12-22 | 2005-06-29 | Dubai Genetics FZ-LLC | Nature-identical erythropoietin |
US20070128174A1 (en) * | 2005-09-21 | 2007-06-07 | Kleinsek Donald A | Methods and compositions for organ and tissue functionality |
PT2078073E (pt) * | 2006-10-12 | 2013-11-11 | Ethicon Inc | Células derivadas do rim e métodos de utilização na reparação e regeneração de tecidos |
US9824107B2 (en) * | 2006-10-25 | 2017-11-21 | Entit Software Llc | Tracking changing state data to assist in computer network security |
ES2725502T3 (es) * | 2007-06-08 | 2019-09-24 | Univ Wake Forest Health Sciences | Terapia celular selectiva para el tratamiento de la insuficiencia renal |
JP5974233B2 (ja) | 2008-11-12 | 2016-08-24 | リージェンメド(ケイマン)エルティーディー. | 単離した腎細胞およびその使用 |
JP6147540B2 (ja) * | 2013-03-29 | 2017-06-14 | 本田技研工業株式会社 | 鞍乗り型車両 |
-
2008
- 2008-06-06 ES ES08768234T patent/ES2725502T3/es active Active
- 2008-06-06 JP JP2010511210A patent/JP2010528658A/ja active Pending
- 2008-06-06 DK DK08768234.0T patent/DK2162529T3/da active
- 2008-06-06 AU AU2008262333A patent/AU2008262333B2/en not_active Expired - Fee Related
- 2008-06-06 CA CA2688265A patent/CA2688265C/en active Active
- 2008-06-06 WO PCT/US2008/007161 patent/WO2008153970A1/en active Application Filing
- 2008-06-06 KR KR1020147033468A patent/KR101632372B1/ko active IP Right Grant
- 2008-06-06 CN CN201310717515.9A patent/CN103865871A/zh active Pending
- 2008-06-06 EP EP08768234.0A patent/EP2162529B1/en active Active
- 2008-06-06 US US12/134,813 patent/US20080305146A1/en active Pending
- 2008-06-06 KR KR1020167008085A patent/KR101804287B1/ko active IP Right Grant
- 2008-06-06 KR KR1020097026740A patent/KR20100035637A/ko not_active Application Discontinuation
- 2008-06-06 CN CN200880102321.5A patent/CN101827933B/zh active Active
-
2014
- 2014-09-29 JP JP2014198530A patent/JP2015062415A/ja not_active Withdrawn
- 2014-12-15 HK HK14112542.2A patent/HK1199059A1/xx unknown
-
2015
- 2015-09-16 US US14/856,043 patent/US9534203B2/en active Active
-
2017
- 2017-02-13 JP JP2017024049A patent/JP6461216B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
AU2008262333B2 (en) | 2014-07-17 |
WO2008153970A1 (en) | 2008-12-18 |
CA2688265A1 (en) | 2008-12-18 |
US20080305146A1 (en) | 2008-12-11 |
JP2010528658A (ja) | 2010-08-26 |
US9534203B2 (en) | 2017-01-03 |
JP2015062415A (ja) | 2015-04-09 |
KR20140147150A (ko) | 2014-12-29 |
KR20100035637A (ko) | 2010-04-05 |
EP2162529A1 (en) | 2010-03-17 |
US20160002603A1 (en) | 2016-01-07 |
CN101827933B (zh) | 2014-01-29 |
KR101632372B1 (ko) | 2016-07-01 |
HK1199059A1 (en) | 2015-06-19 |
KR101804287B1 (ko) | 2017-12-04 |
CA2688265C (en) | 2021-02-16 |
CN103865871A (zh) | 2014-06-18 |
EP2162529B1 (en) | 2019-03-27 |
ES2725502T3 (es) | 2019-09-24 |
CN101827933A (zh) | 2010-09-08 |
KR20160038083A (ko) | 2016-04-06 |
AU2008262333A1 (en) | 2008-12-18 |
JP2017131226A (ja) | 2017-08-03 |
JP6461216B2 (ja) | 2019-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2162529T3 (da) | Selektiv celleterapi til behandling af nyresvigt | |
CY2017016I1 (el) | Αναστολεις πρωτεασωματος | |
DK2068927T3 (da) | Fremgangsmåder til reducering af eosinofilniveauer | |
DK1974806T3 (da) | Fremgangsmåde til rensning af vand | |
ATE461177T1 (de) | Ionenkanal-hemmer | |
DK2183753T3 (da) | Fremgangsmåder til køling | |
DK2574677T3 (da) | Fremgangsmåder til celledyrkning | |
DK2117523T3 (da) | Inhibitorer af AKT-aktivitet | |
DK3428148T3 (da) | Aryloazol-2-yl-cyanoethylaminoforbindelser, fremgangsmåde til fremstilling og fremgangsmåde til anvendelse deraf | |
DK2300497T3 (da) | Fremgangsmåde til oprensning af koagulationsfaktor VIII | |
DK2349132T3 (da) | Apparat til behandling af gerd | |
DK2209900T3 (da) | Anvendelse af bakterier til fremstillingen af bioenergi | |
DK3208269T3 (da) | Inhibitorer af c-fms-kinase | |
DK3225251T3 (da) | Modulering af pro-neurotrofinaktivitet | |
DK3192520T3 (da) | Terapeutiske midler til reducering af niveauerne af parathyreoideahormon | |
DK2293816T3 (da) | Fremgangsmåder til behandling af reumatoid arthritis | |
DK2111555T3 (da) | Diagnosticering af præeklampsi | |
DK2342346T3 (da) | Thermotoga til behandling af biomasse | |
DK2167095T3 (da) | Phenothiazin-forbindelser til behandling af let kognitiv svækkelse | |
DK2358714T3 (da) | Alkylcyclohexylethere af dihydrotetraazabenzoazulener | |
DK2114147T3 (da) | Reduktion af bivirkninger af tramadol | |
DK3214083T3 (da) | Fremgangsmåde til fremstilling af quinolonforbindelser | |
DK2117565T3 (da) | Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme | |
BRPI0814730A2 (pt) | consecutive acunpuncture device and cartridge for consecutive acunpuncture device | |
ITMI20061261A1 (it) | Assemblati per dispositivi elettrochimici |